本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Immix Biopharma, Inc

2.55
+0.14005.81%
盘后2.550.00000.00%16:52 EDT
成交量:10.18万
成交额:25.44万
市值:7,102.35万
市盈率:-3.64
高:2.59
开:2.43
低:2.42
收:2.41
数据加载中...
2022/05/27

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/19

重要事件披露

8-K - Current report
2022/01/12

重要事件披露

8-K - Current report
2022/01/03

重要事件披露

8-K - Current report
2021/12/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/20

重要事件披露

8-K - Current report
2021/12/13

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/13

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/01

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/04

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/28

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/15

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/15

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/06

SEC问询函

CORRESP [Cover] - Correspondence